Respiratory Disorders Clinical Trial
Official title:
Timing of Elective Caesarean Section and Neonatal Morbidity - a Randomised Multicentre Study
The caesarean section rate is rising globally. About 10% of the newborns are submitted to a
neonatal department after planned caesarean section, primarily with respiratory disorders.
More children are submitted if caesarean is performed earlier in pregnancy.
Study hypothesis: More newborns are admitted after planned caesarean at 38 weeks and 3 days
of gestation than after 39 weeks and 3 days of gestation.
Aim of study: To compare elective caesarean section performed at 38 weeks and 3 days of
gestation with 39 weeks and 3 days of gestation. According to this timing to determine the
proportion of newborns admitted within 48 hours after birth.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT00844935 -
Electrocardiographic Autonomic Function Measures in Mechanically Ventilated Patients
|
N/A | |
| Completed |
NCT01443845 -
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)
|
Phase 4 | |
| Completed |
NCT01395849 -
Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
|
N/A | |
| Completed |
NCT03557645 -
Ventilator Hyperinflation and Hemodynamics
|
N/A | |
| Completed |
NCT03281876 -
A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.
|
Phase 2 | |
| Completed |
NCT01395862 -
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
|
N/A | |
| Completed |
NCT01476046 -
Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.
|
Phase 1 | |
| Completed |
NCT01587807 -
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057
|
Phase 1 | |
| Completed |
NCT03443427 -
A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine
|
Phase 2 | |
| Completed |
NCT01360398 -
Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly
|
N/A | |
| Completed |
NCT03201211 -
A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults
|
Phase 1 | |
| Completed |
NCT02075541 -
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.
|
Phase 2 | |
| Completed |
NCT00455767 -
Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients
|
Phase 2 | |
| Withdrawn |
NCT01505556 -
Proprioceptive Postural Control and Diaphragm Paresis
|
||
| Completed |
NCT01505582 -
Inspiratory Muscle Training and Low Back Pain
|
N/A | |
| Completed |
NCT02322671 -
Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects
|
Phase 1 | |
| Completed |
NCT01818024 -
A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT02316379 -
Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration
|
Phase 1/Phase 2 | |
| Completed |
NCT01516437 -
A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD
|
N/A | |
| Recruiting |
NCT02272049 -
Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults
|
Phase 1/Phase 2 |